Multiple Sclerosis Research Findings Top SPT Week in Review

Article

Top news of the week from Specialty Pharmacy Times.

5. Investigational HIV Therapy Further Demonstrates Efficacy in Phase 3 Trial

Study evaluates doravirine once daily compared with ritonavir-boosted darunavir, each taken in combination with other antiretroviral agents. Read more.

4. FDA Approves Extended-Release Injectable Suspension for Schizophrenia

Officials with the FDA have approved risperidone (Perseris, Indivior) for extended-release injectable suspension for the treatment of schizophrenia in adults. Read more.

3. FDA Grants Fast Track Designation to Hepatitis B Drug

The FDA recently granted Fast Track designation to Assembly Biosciences, Inc’s novel treatment for patients with chronic hepatitis B virus (HBV) infection. Read more.

2. Use of Truvada for HIV Prevention Associated with Decline in New US Diagnoses

Nationwide analysis of Truvada for pre-exposure prophylaxis use finds uptake associated with significant decrease in new HIV infections. Read more.

1. Research Sheds Light on New Drug Targets for Regenerative MS Therapies

Study finds that several multiple sclerosis drug candidates inhibit the same enzyme to stimulate myelin regeneration. Read more.

Related Videos
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
Image Credit: SciePro - stock.adobe.com
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.